This clinical update module provides two recent meta-analyses
that shed some light on the differential efficacy of different classes
of agents including the relative efficacy of venlafaxine compared
with other agents for the treatment of major depression.
Learning objectives:
- Review two recent meta-analyses that shed some light on the differential efficacy of different classes of agents.
- Examine the relative efficacy of venlafaxine compared with other agents including selective serotonin reuptake inhibitors or SSRIs and tricyclic antidepressants or TCAs for major depression
- Understand the effectiveness of switching to a second SSRI versus a non-SSRI antidepressant for SSRI-resistant major depressive disorder.